AORT logo

AORT
Artivion Inc

315
Mkt Cap
$1.8B
Volume
448,445.00
52W High
$48.25
52W Low
$22.22
PE Ratio
188.43
AORT Fundamentals
Price
$37.63
Prev Close
$36.51
Open
$37.81
50D MA
$37.39
Beta
0.91
Avg. Volume
392,345.94
EPS (Annual)
$0.2069
P/B
4.02
Rev/Employee
$245,183.33
$2,344.66
Loading...
Loading...
News
all
press releases
Tudor Investment Corp ET AL Sells 39,388 Shares of Artivion, Inc. $AORT
Tudor Investment Corp ET AL cut its holdings in Artivion, Inc. (NYSE:AORT - Free Report) by 36.7% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 68,021...
MarketBeat·1h ago
News Placeholder
More News
News Placeholder
Artivion (NYSE:AORT) Upgraded by Wall Street Zen to "Buy" Rating
Wall Street Zen raised shares of Artivion from a "hold" rating to a "buy" rating in a research report on Saturday...
MarketBeat·7h ago
News Placeholder
LADENBURG THALM/SH SH Upgrades Artivion (NYSE:AORT) to Buy
LADENBURG THALM/SH SH upgraded shares of Artivion from a "neutral" rating to a "buy" rating and set a $42.00 price target on the stock in a research note on Friday...
MarketBeat·24h ago
News Placeholder
Artivion Secures FDA Approval for NEXUS Aortic Arch System
AORT jumps after FDA approves NEXUS Aortic Arch System, unlocking a potential Endospan acquisition and advancing minimally invasive care for high-risk patients.
Zacks·3d ago
News Placeholder
Artivion (AORT) Soars 5.3%: Is Further Upside Left in the Stock?
Artivion (AORT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks·3d ago
News Placeholder
Needham & Company LLC Reiterates "Buy" Rating for Artivion (NYSE:AORT)
Needham & Company LLC reaffirmed a "buy" rating and set a $58.00 price target on shares of Artivion in a report on Tuesday...
MarketBeat·4d ago
News Placeholder
Artivion (NYSE:AORT) Shares Gap Up - Time to Buy?
Artivion (NYSE:AORT) Shares Gap Up - Time to Buy...
MarketBeat·4d ago
News Placeholder
Artivion Announces U.S. FDA Approval of the NEXUS Aortic Arch System
Artivion Announces U.S. FDA Approval of the NEXUS Aortic Arch System Artivion Announces U.S. FDA Approval of the NEXUS Aortic Arch System PR Newswire ATLANTA, April 7, 2026 Endospan's NEXUS branched...
PR Newswire·4d ago
News Placeholder
SG Americas Securities LLC Raises Stake in Artivion, Inc. $AORT
SG Americas Securities LLC boosted its position in shares of Artivion, Inc. (NYSE:AORT - Free Report) by 578.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange...
MarketBeat·5d ago
News Placeholder
Artivion (NYSE:AORT) Shares Gap Down - Should You Sell?
Artivion (NYSE:AORT) Shares Gap Down - Here's Why...
MarketBeat·9d ago
<
1
2
...
>

Latest AORT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.